ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Oncology Institute Inc

Oncology Institute Inc (TOI)

0.1322
-0.0478
(-26.56%)
Closed November 21 4:00PM
0.1342
0.002
(1.51%)
After Hours: 7:59PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.1342
Bid
0.1345
Ask
0.1399
Volume
15,092,442
0.128 Day's Range 0.154899
0.1316 52 Week Range 2.50
Market Cap
Previous Close
0.18
Open
0.15
Last Trade Time
Financial Volume
$ 2,042,705
VWAP
0.135346
Average Volume (3m)
293,346
Shares Outstanding
75,559,075
Dividend Yield
-
PE Ratio
-9.99
Earnings Per Share (EPS)
-1.1
Revenue
324.24M
Net Profit
-83.07M

About Oncology Institute Inc

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financia, counsel... The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financia, counseling, clinical trials, comprehensive lab testing, and end-of-life counseling.The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Show more

Sector
Offices Of Medical Doctors
Industry
Blank Checks
Headquarters
Wilmington, Delaware, USA
Founded
2021
Oncology Institute Inc is listed in the Offices Of Medical Doctors sector of the NASDAQ with ticker TOI. The last closing price for Oncology Institute was $0.18. Over the last year, Oncology Institute shares have traded in a share price range of $ 0.1316 to $ 2.50.

Oncology Institute currently has 75,559,075 shares outstanding. The market capitalization of Oncology Institute is $13.60 million. Oncology Institute has a price to earnings ratio (PE ratio) of -9.99.

TOI Latest News

The Oncology Institute Reports Third Quarter 2024 Financial Results

CERRITOS, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United...

The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California

CERRITOS, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Today, the Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) announced that they have received certification to begin administering...

The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call

CERRITOS, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that...

The Oncology Institute Joins Lantern’s Cancer Care Network of Excellence

CERRITOS, Calif., Oct. 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the nation, has joined Lantern’s leading...

The American Journal of Managed Care® and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care

CERRITOS, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Today, the Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) shared its partnership with the American Journal of Managed Care® (AJMC...

The Oncology Institute of Hope & Innovation Launches Oregon Market

CERRITOS, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the nation, is proud to announce its expansion...

The Oncology Institute Announces CFO Transition

CERRITOS, Calif., Sept. 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), today announced that Chief Financial Officer, Mihir Shah, will...

The Oncology Institute Reports Second Quarter 2024 Financial Results and Updates Full Year 2024 Guidance

CERRITOS, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.1508-52.91228070180.2850.2892660.131622877070.18430102CS
4-0.2035-60.26058631920.33770.36760.13167060760.20461632CS
12-0.2198-62.09039548020.3540.39940.13162933460.22628061CS
26-0.4858-78.35483870970.620.67330.13162283100.32283876CS
52-2.1158-94.03555555562.252.50.13162098260.8874706CS
156-8.3458-98.41745283028.4812.660.13162387031.80810103CS
260-9.7258-98.63894523339.8612.660.13162375091.81932139CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FBRXForte Biosciences Inc
$ 13.60
(129.53%)
28.92M
QSIQuantum Si Inc
$ 1.39
(119.59%)
279.33M
XCURExicure Inc
$ 11.01
(89.18%)
22.91M
AGFYAgrify Corporation
$ 37.4635
(68.00%)
921.45k
SLXNSilexion Therapeutics Corporation
$ 0.3495
(54.51%)
198.66M
SKKSKK Holdings Limited
$ 4.55
(-47.28%)
816.93k
QMMMQMMM Holdings Limited
$ 0.713999
(-43.78%)
4.61M
XTKGX3 Holdings Company Ltd
$ 0.0901
(-37.82%)
5.95M
PRFXPainReform Ltd
$ 1.02
(-27.14%)
5.09M
GLEGlobal Engine Group Holding Ltd
$ 3.81
(-26.59%)
230.23k
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.191
(17.39%)
662.68M
DBGIDigital Brands Group Inc
$ 0.1345
(15.35%)
326.45M
NVDANVIDIA Corporation
$ 145.89
(-0.76%)
309.57M
QSIQuantum Si Inc
$ 1.39
(119.59%)
283.09M
SLXNSilexion Therapeutics Corporation
$ 0.3495
(54.51%)
200.06M

TOI Discussion

View Posts
glenn1919 glenn1919 1 day ago
TOI..........................https://stockcharts.com/h-sc/ui?s=TOI&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 3 months ago
TOI
New 52 week low
👍️0
boston127 boston127 12 months ago
Thanks. I like it.

I may approach them about reselling my company's product.
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
MREO MY FAV BIO
👍️0
boston127 boston127 1 year ago
I did. Where do you recommend next?

Is this going to be a better play soon? I am in heavy, and in the red, with LGHL. would appreciate a quick look and feedback on that board, not here. TOI has so many good things going for it - owned by institutions - it is going to be hard for me not to eventually get in here.
👍️0
boywonder1 boywonder1 1 year ago
The chart has contradictions like yourself and you're posting history ‼️‼️2😂
👍️ 1 💯 1
TrendTrade2016 TrendTrade2016 1 year ago
Glad you listened
👍️0
boston127 boston127 1 year ago
You were correct. Took a major haircut.

Glad I did not jump in. Thanks. What do you like?
👍️0
boston127 boston127 1 year ago
The Warrants do not expire

until November, 2026. I may start adding them. I can get 10 Ws for every 1 Common.
👍️0
boston127 boston127 1 year ago
What important indicators?

TOI appears to be in a strong bullish trend. Its 200-day moving average is upwards sloping and the MACD histogram is above 0. Comparative Relative Strength analysis shows that this issue is outperforming the S&P 500.
As of 3:00 PM ET Friday, 11/03/2023
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
important indicators going down as stock is going up...red flag!!!!
👍️0
boston127 boston127 1 year ago
Can you explain?

Do you know anything about the warrants? Strike price, expiration date, etc.
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
CHART HAS SOME CONTRADICTIONS
👍️0
boston127 boston127 1 year ago
It sure is acting perky.

Nice move AH and Premarket. I'm going to jump in today if the move north continues.
👍️0
boston127 boston127 1 year ago
Common goes down.

Warrants go up on very light volume. Hard to figure.
👍️0
hedge_fun hedge_fun 1 year ago
She was under 40 cents in mid June……

I would say she’s is already flying.

Been my best play this year.
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
TOI...READY TO FLY
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
TOI...READY TO FLY
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
MONSTER IN DA MAKING
👍️0
hedge_fun hedge_fun 1 year ago
It’s tripled since mid-June…..
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
MONSTER PLAY HERE....
👍️0
TrendTrade2016 TrendTrade2016 1 year ago
TOI BEAUTY BOTTOM HERE ...AI CANCER PLAY
👍️0
hedge_fun hedge_fun 1 year ago
Company repurchasing more shares. Nice…..
👍️0
hedge_fun hedge_fun 1 year ago
August starting out like July…….
👍️0
hedge_fun hedge_fun 1 year ago
On watch. Thx
👍️0
CaptPete1776 CaptPete1776 1 year ago
Keep eye in $Getr over .55. That’s the breakout spot could explode over .70. I’ve been swinging this also.
👍️0
CaptPete1776 CaptPete1776 1 year ago
I have some left yes just don’t want to get to greedy
👍️0
hedge_fun hedge_fun 1 year ago
I hope you’re still holding some. I’m enjoying the ride.
👍️0
CaptPete1776 CaptPete1776 1 year ago
Looks great. I sold some here .89
👍️0
hedge_fun hedge_fun 1 year ago
I don’t want July to end!!!
👍️0
CaptPete1776 CaptPete1776 1 year ago
Holding in today's nasdaq slide and up on the day. .90 is coming next
👍️0
CaptPete1776 CaptPete1776 1 year ago
Yes definitely
👍️0
hedge_fun hedge_fun 1 year ago
Been a nice move the past 2 weeks……
👍️0
hedge_fun hedge_fun 1 year ago
The low volume dips with 100 share trades……

are fishy.

Maybe this proves to be support.

Long term hold for me.
👍️0
CaptPete1776 CaptPete1776 1 year ago
Let’s get more good new out. It’s been holding strong since the last news about stock repurchase plan.
👍️0
hedge_fun hedge_fun 1 year ago
On June 14, 2023, the Board of Directors of The Oncology Institute, Inc. (the “Company”) approved a share repurchase program with authorization to purchase up to 5 million shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). The Company may repurchase shares from time to time through one or more securities broker-dealers, in open market purchases and negotiated purchases, in each case at price per share not to exceed $0.75. Shares repurchased by the Company pursuant to the share repurchase program shall be returned to the status of authorized but unissued shares of Common Stock.

In connection with the foregoing, on June 14, 2023, the Company entered into a limited consent (the “Limited Consent”), dated as of June 14, 2023, to that certain Facility Agreement, dated as of August 9, 2022 (the “Facility Agreement”), by and among the Company, as borrower, certain of the Company’s subsidiaries from time to time party thereto as guarantors and Deerfield Partners, L.P., as agent for itself and the lenders (collectively, “Deerfield”). The Limited Consent permits the repurchase by the Company on or prior to June 16, 2023, of up to 5,000,000 shares of the Company’s Common Stock in one or more open market or negotiated purchases, in each case at price per share not to exceed $0.75. The actual timing and amount of repurchases are subject to business and market conditions, corporate and regulatory requirements, stock price, acquisition opportunities and other factors. The Limited Consent does not obligate the Company to repurchase any amount of shares, and there can be no assurance that any shares will be repurchased. The Limited Consent also grants a one-time waiver under the Facility Agreement of certain delivery of any notice requirements.

The foregoing description of the Limited Consent does not purport to be complete and is qualified in its entirety by reference to the full text of the Limited Consent, a copy of which is attached hereto as Exhibit 10.1 and incorporated herein by reference.
👍️0

Your Recent History

Delayed Upgrade Clock